Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Liver TransplantHemorrhage, Surgical
Interventions
DEVICE

Cell Salvage Autotransfusion: SAME™ device

"* Intervention studied: processing of salvaged blood using the SAME™ autotransfusion device~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Treatment group.~All perioperative measures will be performed according to international, national and in-house standards."

DEVICE

Cell Salvage Autotransfusion: Autolog™ device

"* Intervention studied: processing of salvaged blood using the Autolog™ (Medtronic) autotransfusion device (in-house standard device).~* Population studied: 20 patients planned to undergo high-risk liver transplantation.~* Control group~All perioperative measures will be performed according to international, national and in-house standards."

Trial Locations (1)

1211

Geneva University Hospitals, Geneva

All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

Eduardo Schiffer

OTHER

NCT06357455 - Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery | Biotech Hunter | Biotech Hunter